WPRIM Management System> DCMS> Journal of International Oncology> 2016> 43> 2

Volume: 43 Issue: 2

1. Discoidin domain receptor 2 and its expression and role in tumor Page:126—129
2. Efficiency and prognostic factors of transcatheter arterial chemoembolization, radiofrequency ablation combined with intensity modulated radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus Page:99—102
3. Inhibitory effect of dexamethasone on residual Lewis lung cancer cells in mice after palliative surgery Page:81—85
4. Application of near infrared fluorescence imaging with indocyanine green in sentinel node biopsy for cN0 oral carcinoma Page:86—89
5. Expression and clinical significance of serum chemokines in patients with lung cancer Page:90—94
6. Analysis of risk factors associated with postoperative lower respiratory infections in the elderly patients with lung carcinoma Page:95—98
7. Prophylactic use of antibiotics for cancer inpatients with leukocyte count ≤ 1 × 109/L Page:103—105
8. Expression and functional mechanism of high mobility group A2 in neoplasm Page:106—109
9. Role and regulatory mechanism of microRNA-449 in cancer Page:110—112
10. Anti-cancer effect of metformin and regulation on HIF-1α Page:113—115
11. Research on histone deacetylase as a target for anti-cancer therapy Page:116—118
12. The correlation between nucleolin and biological behavior of tumor Page:119—121
13. Immunosenescence and its role in cancer Page:122—125
14. Voltage-gated potassium channel Kv1.5 and cancer Page:130—132
15. The advances in diagnosis and treatment of non-small cell lung cancer with PET-CT Page:133—137
16. Research progress of primary extramedullary plasmacytoma Page:138—140
17. Plasmacytoma variant translocation 1 in cancer Page:141—144
18. Research advances on second primary malignancies of oral cavity following radiotherapy for nasopharyngeal carcinoma Page:145—147
19. Progress of maintenance therapy for advanced non-small-cell lung cancer Page:148—151
20. Application of circulating DNA in colorectal cancer Page:152—154
21. SALL4 and its clinical application value in non-germ cell tumors Page:155—158